Organoids & 3D modelsconfirmed
ProxyBio
University of Arizona spinout pairing patient-derived organoids with an AI platform for drug screening, preclinical safety and patient profiling.
Notable
Markets a preclinical safety product (ProxyTOX).
Related deals
- May 2026Venture financing, SeedInvestment to scale patient-derived organoid and AI products for drug response and safety.
Related updates
No related news yet.